WFG Advisors’s Rosetta Genomics ROSG Stock Holding History
Bought
Maintained
Sold
Other funds holding ROSG
HCM
WFG Advisors's ROSG Position: Q1 2014 in Review
WFG Advisors sold out of Rosetta Genomics (ROSG) in Q1 2014, closing a stake of 51 shares — an estimated $2K sold.
WFG Advisors first reported a position in ROSG in Q4 2013 and held it in 1 quarter. The position peaked at $2K in Q4 2013. 18 funds tracked by Wall St. Rank hold ROSG as of Q1 2014.
- WFG Advisors reported no remaining Rosetta Genomics position as of Q1 2014 after selling out during the quarter.
- WFG Advisors sold 51 Rosetta Genomics shares in Q1 2014, an estimated $2K.
- WFG Advisors first reported a position in Rosetta Genomics in Q4 2013 and held it in 1 quarter.
- WFG Advisors's Rosetta Genomics position peaked at $2K in Q4 2013.
- 18 funds tracked by Wall St. Rank held Rosetta Genomics as of Q1 2014.
Based on WFG Advisors's 13F filing for Q1 2014, filed 24 Apr 2014.